Bicycle Therapeutics plc held its annual general meeting of shareholders on June 17, 2025. The meeting included several proposals, all of which were approved. These included the re-election of Alessandro Riva and Stephen Sands as directors, the ratification and re-appointment of PricewaterhouseCoopers LLP as both the U.S. independent registered public accounting firm and the U.K. statutory auditors, and the authorization for the Audit Committee to determine the auditors' remuneration for the year ending December 31, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.